NEW DELHI: The Rajiv Gandhi Cancer Institute and Research Centre here has officially launched a new “Sonablate HIFU” service for treatment of prostate cancer patients.

“Sonablate HIFU on initial use is very patient-friendly for those suffering from prostate cancer as there is no immediate morbidity which is expected if the patient chooses radical surgery. The long-term side-effects are also not expected since the treatment is done by sound waves,” said Dr. Sudhir Rawal, who claims to have performed more than 15 HIFU procedures using Sonablate HIFU in Delhi….

‘Convenient treatment’

 

 

“The treatment is most convenient as the patient is admitted only for one day and, there is no blood loss during the procedure, and the patient can return to work very quickly,” he added.

Head of the Rajiv Gandhi Cancer Institute and Research Centre D. S. Negi said: “We always believe in providing the best treatment option to patients suffering from prostate cancer.”

Prostate cancer is one of the most common non-skin cancers among men and one of the leading causes of male deaths due to cancer. Though prostate cancer generally afflicts the elderly, it is not uncommon among young patients above 40. In most cases it spreads quickly, but in some cases it can be very slow-growing and difficult to identify. According to medical experts, when the tumour becomes more advanced, patients experience a weak urinary stream, inability to urinate, pain or burning sensation during urination and blood in urine.

Tags: Cancer, Mesothelioma, Prostate Cancer

This entry was posted on Sunday, July 19th, 2009 at 6:38 am and is filed under Cancer. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.